Ammon Haymond, | |
1492 S Silicon Way Ste A, St George, UT 84770-7156 | |
(435) 275-8911 | |
Not Available |
Full Name | Ammon Haymond |
---|---|
Gender | Male |
Speciality | Community Health Worker |
Location | 1492 S Silicon Way Ste A, St George, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700237740 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Secondary |
172V00000X | Community Health Worker | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ammon Haymond, 1492 S Silicon Way Ste A, St George, UT 84770-7156 Ph: (435) 275-8911 | Ammon Haymond, 1492 S Silicon Way Ste A, St George, UT 84770-7156 Ph: (435) 275-8911 |
News Archive
In this post in BMJ's "Yankee Doodling," Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation "if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment."
The study results revealed that patients with a history of heart disease who stopped taking a low-dose daily aspirin had a 60% increased risk of having a heart attack over the three-year follow-up, compared with patients who continued the daily aspirin, says study researcher Luis A. Garcia Rodriguez, director of the Spanish Center for Pharmacoepidemiologic Research (CEIFE) in Madrid. The study is published in the British Medical Journal.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration has issued 510(k) clearance to the Simplexa Influenza A H1N1 (2009) test on the 3M Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is the first to be cleared by the FDA for use as an aid in the detection and differentiation of influenza A and 2009 H1N1 influenza viral RNA.
Patients who receive cardiac positron emission testing (PET) imaging instead of single photon emission computed tomography scan experienced a significant increase in the detection of severe obstructive coronary artery disease, according to researchers at the Intermountain Medical Center Heart Institute in Salt Lake City.
While nursing homes are the place where an estimated 30 percent of Americans die, there currently exists no way to compare which institutions do a better job at managing end of life care. A new study appearing this week in the Journal of Palliative Medicine is starting a discussion over the need to create end of life quality measures in order to both inform consumers and provide nursing homes with incentive to improve care.
› Verified 8 days ago